Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy
NCT ID: NCT00177112
Last Updated: 2008-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
275 participants
INTERVENTIONAL
2005-06-30
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
NCT03099863
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
NCT03719755
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
NCT01450800
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
NCT07239219
Chlorhexidine Lavage for Recurrent Urinary Tract Infection
NCT06598514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
clean patient preparation for cystoscopy
sterile patient preparation for cystoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing routine outpatient flexible cystoscopy
Exclusion Criteria
* Patients with an indwelling catheter
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Minnesota
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyle Anderson, MD
Role: PRINCIPAL_INVESTIGATOR
VAMC Minneapolis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VAMC Minneapolis
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3519A
Identifier Type: -
Identifier Source: secondary_id
0412M65852
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.